维普中文期刊产品整合服务
68篇 您的检索式:作者名="Assaraf"
    题名 作者 年代 出处 被引量
1Arabinogalac- tan - folic acid - drug conjugate for targeted delivery and target - ac- tivated release of anticancer drugs to folate receptor - overexpress- ing cells 显示文摘PINHASSI R I ASSARAF Y G FARBER S 2010Biomacromolecules2010,11,1:1
2Arabinogalactan folic acid drug conjugate for targeted delivery and targe- tactivated release of anticaneer drugs to folate receptor- overexpressing cells显示文摘Pinhassi RI Assaraf YG Farber S 2010Biomacromolecules2010,11,1:1
3Membrane fluidization by ether, other anesthetics, and certain agents abolishes P-glycoprotein ATPase activity and modulates efflux from multidrug-resistant cells显示文摘Regev R Assaraf Y G Eytan G D 0,,:1
4Disruption of Pglycoprotein anticancer drug efflux activity by a small recombinant single-chain Fv antibody fragment targeted to an extracellular epitope显示文摘Hans-Cohen M Assaraf YG Binyamin L 2004Int J Cancer2004,109,5:1
5Brain erythropoietin receptor expression in Alzheimer disease and mild cognitive impairment 显示文摘i Assaraf MI Diaz Z Liberman A 2007J Neuropathol Exp Neuro12007,66,5:1
6Cytoplasmic confinement of breast cancer resistance protein (BCRP/ABCG2) as a novel mecha-nism of adaptation to short-term folate deprivation 显示文摘Ifergan I Jansen G Assaraf YG 2005Mol Phamacol2005,67,4:1
7Methotrexate nor- malizes up-regulated folate pathway genes in rheumatoid arthritis显示文摘Blits M Jansen G Assaraf YG 2013Arthritis Rheum2013,65,11:1
8Functional reconstitution of P-glycoprotein reveals an apparent near stoichiometric drug transport to ATP hydrolysis显示文摘Eytan GD Regev R Assaraf YG 1996J Biol Chem1996,271,6:1
9Antifolates in cancer therapy : structure, activity and mechanisms of drug resistance显示文摘Gonen N Assaraf YG 2012Drug Resist Up- dat2012,15,4:1
10Inhibition of the PI3K-Akt signaling pathway disrupts ABCG2-rich extracel- lular vesicles and overcomes muhidrug resistance in breast cancer cells 显示文摘Goler-Baron V Sladkevich I Assaraf YG 2012Biochem Pharmacol2012,83,10:1
11Inhibition of the PI3K- Akt signaling pathway disrupts ABCG2-rich extracellular vesi- cles and overcomes muhidrug resistance in breast cancer cells 显示文摘Goler-Baron V Sladkevich I Assaraf YG 2012Biochem Pharmacol2012,83,10:1
12Antifolates in cancer therapy: structure, activity and mechanisms of drug resistance显示文摘Gonen N Assaraf YG 2012Drug Resist Updat2012,15,4:1
13Inhibition of the PI3K-Akt signaling pathway disrupts ABCG2-rich extracellular vesicles and overcomes multidrug resistance in breast cancer cells 显示文摘Goler-Baron V Sladkevich I Assaraf YG 2012Bioehem Pharmacol2012,83,10:1
14Disruption of P-glycoprotein anticancer drug efflux activity by a small recombinant single-chain Fv antibody fragment targeted to an extracellular epitope显示文摘Haus-Cohen M Assaraf YG Binyamin L 2004Int J Cancer2004,109,5:1
15Astroglial cytoprotection by erythropoietin preconditioning implications for ischemic and degenerative CNS disorders显示文摘Diaz Z Assaraf M 2005Neurochem2005,93,2:1
16Beta-casein-based nanovehicles for oral delivery of chemotherapeutic drugs: drug-protein interactions and mitoxantrone loading capacity显示文摘Shapira A Markman G Assaraf YG 2010Nanomedicine2010,6,4:1
17Cytoplasmic confinement of breast cancer resistance protein (BCRP/ABCG2) as a novel mechanism of adaptation to short-term folate deprivation 显示文摘IFERGAN I JANSEN G ASSARAF YG 2005Mol Pharmacol2005,67,4:1
18Molecular basis of antifolate resistance 显示文摘Assaraf YG 2007Cancer Metastasis Rev2007,26,1:1
19The role of multidrug resistance effiux transporters in an- tifolate resistance and folate homeostasis 显示文摘Assaraf Y G 2006Drug Resistant Update2006,9,4:1
20Differential reversal of lipophilic antifolate resistance in mammalian cells with modulations of the multidrug resistance phenotype 显示文摘 Borgnia MJ 1993Anti-cancerDrugs1993,4,3:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费